tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

BRTX Stock Latest News

BioRestorative Therapies’ IFATS 2024 Presentation to Feature ThermoStem® Platform’s Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 Drugs
Press ReleasesBioRestorative Therapies’ IFATS 2024 Presentation to Feature ThermoStem® Platform’s Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 Drugs
1d ago
BRTX
BioRestorative Therapies Clarifies Press Release Usage in Filings
PremiumCompany Announcements
BioRestorative Therapies Clarifies Press Release Usage in Filings
1M ago
8K
BRTX
BRTX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
BRTX Upcoming Earnings Report: What to Expect?
1M ago
BRTX
BioRestorative Therapies Issues Financial Update Notice
PremiumCompany Announcements
BioRestorative Therapies Issues Financial Update Notice
1M ago
8K
BRTX
BioRestorative Therapies’ Chief Scientist Named New Section Editor of the Prestigious Journal of Translational Medicine
PremiumPress Releases
BioRestorative Therapies’ Chief Scientist Named New Section Editor of the Prestigious Journal of Translational Medicine
2M ago
BRTX
BioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program
PremiumPress ReleasesBioRestorative Therapies Announces Notice of Allowance for Patent Covering Fundamental Aspect of ThermoStem® Metabolic Disease Program
3M ago
BRTX
BioRestorative Therapies announces notice of allowance for ThermoStem patent
Premium
The Fly
BioRestorative Therapies announces notice of allowance for ThermoStem patent
3M ago
BRTX
BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results
Premium
Press Releases
BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results
3M ago
BRTX
BioRestorative Therapies reports Q1 EPS (33c) vs. ($1.93) last year
PremiumThe Fly
BioRestorative Therapies reports Q1 EPS (33c) vs. ($1.93) last year
3M ago
BRTX
BioRestorative Therapies regains compliance with Nasdaq listing rule
PremiumThe Fly
BioRestorative Therapies regains compliance with Nasdaq listing rule
3M ago
BRTX
BioRestorative in discussions for potential license agreement for ThermoStem
PremiumThe Fly
BioRestorative in discussions for potential license agreement for ThermoStem
3M ago
BRTX
BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease Program
PremiumPress Releases
BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease Program
3M ago
BRTX
BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference
PremiumPress ReleasesBioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference
4M ago
BRTX
BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice
Premium
Press Releases
BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice
4M ago
BRTX
BioRestorative Therapies Provides First Quarter 2024 Business Update
Premium
Press Releases
BioRestorative Therapies Provides First Quarter 2024 Business Update
4M ago
BRTX
BioRestorative develops new therapeutic candidate using ThermoStem platform
PremiumThe Fly
BioRestorative develops new therapeutic candidate using ThermoStem platform
5M ago
BRTX
BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity
PremiumPress Releases
BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity
5M ago
BRTX
BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
PremiumPress Releases
BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
5M ago
BRTX
BioRestorative Therapies announces commercial agreement with Cartessa
PremiumThe Fly
BioRestorative Therapies announces commercial agreement with Cartessa
5M ago
BRTX
BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology
PremiumPress ReleasesBioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology
5M ago
BRTX
BioRestorative’s BRTX-100 trial to use sham injection control, says Roth MKM
Premium
The Fly
BioRestorative’s BRTX-100 trial to use sham injection control, says Roth MKM
5M ago
BRTX
BioRestorative announces FDA clearance of Phase 2 BRTX-100 study protocol
Premium
The Fly
BioRestorative announces FDA clearance of Phase 2 BRTX-100 study protocol
5M ago
BRTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >